Loading clinical trials...

Usefulness of Therapy Monitoring by Means of [(18)F]Fluoroethyltyrosine-Positron Emission Tomography (FET-PET) in Glioblastoma Multiforme Patients | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNCT01089868

Usefulness of Therapy Monitoring by Means of [(18)F]Fluoroethyltyrosine-Positron Emission Tomography (FET-PET) in Glioblastoma Multiforme Patients

The aim of this study is to establish FET-PET as an additional therapy assessment parameter in patients diagnosed with a glioblastoma multiforme receiving radiochemotherapy and adjuvant chemotherapy a...

Lead sponsor: Ludwig-Maximilians - University of Munich•3 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITINGPhase 1

Sonodynamic Therapy in Patients With Recurrent GBM

NCT06039709 · Recurrent Glioblastoma, Glioblastoma Multiforme, and more

RECRUITINGPhase 1/2

Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors

NCT06814496 · Melanoma, Medullary Thyroid Cancer, and more

RECRUITINGNA

Application of FET-PET in Fusion With MRI in the Treatment of Glioblastoma Multiforme [TYR-GLIO]

NCT06466031 · Glioblastoma Multiforme

RECRUITINGPhase 1/2

HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM

NCT03596086 · Glioblastoma Multiforme, Astrocytoma, Grade III

RECRUITING

Targeted Pediatric High-Grade Glioma Therapy

NCT05839379 · High Grade Glioma, Diffuse Intrinsic Pontine Glioma, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: August 7, 2012Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment79

Start dateJan 2007

Last updatedAug 7, 2012

Condition

Glioblastoma Multiforme

Locations shown

Department of Stereotactic Neurosurgery

Freiburg im Breisgau, Baden-Wurttemberg

University Hospital Munich, Department of Neurosurgery

Munich, Bavaria

University Hospital Bonn, Department of Neurosurgery

Bonn, North Rhine-Westphalia

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 7, 2012Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions